Nasal delivery of peptides: An in vitro cell culture model for the investigation of transport and metabolism in human nasal epithelium

Journal of Controlled Release

Volumn 53, Issue 1-3, 1998, Pages 195-203

  Kissel, Thomas ^a   Werner, Ute ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Cell culture model; Human nasal epithelial cells; Nasal metabolism; Nasal transport; Peptides

Indexed keywords

METENKEPHALIN; PROTIRELIN; RECOMBINANT HUMAN INSULIN;

CELL CULTURE; CONFERENCE PAPER; DRUG ABSORPTION; DRUG DISTRIBUTION; DRUG METABOLISM; DRUG PENETRATION; DRUG TRANSPORT; ENZYME DEGRADATION; HUMAN; HUMAN CELL; INTRANASAL DRUG ADMINISTRATION; MOLECULAR WEIGHT; PRIORITY JOURNAL; PROTEIN TRANSPORT;

ADMINISTRATION, INTRANASAL; AMINO ACID SEQUENCE; ANIMALS; BIOLOGICAL TRANSPORT; CELLS, CULTURED; ENKEPHALIN, METHIONINE; HUMANS; INSULIN; OLFACTORY MUCOSA; RABBITS; THYROTROPIN-RELEASING HORMONE;

EID: 0032580451     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(97)00253-8     Document Type: Conference Paper

References (39)

1. Woodyatt R.T. The clinical use of insulin. J. Metab. Res. 2:1922;793.
2. Rote Liste 1997, Editio Cantor, Aulendorf, Germany, 1997.
3. Y.W. Chien, Transnasal Systemic Medications: Fundamentals, Development Concepts and Biomedical Assessments, Elsevier, Amsterdam, 1985.
4. O'Hagan D.T., Illum L. Absorption of peptides and proteins from the respiratory tract and the potential of development of locally administered vaccine. CRC Crit. Rev. Ther. Drug Carrier Syst. 7:1990;35-97.
5. Sakane T., Akizuki M., Yoshida M., Yamashita S., Nadai T., Hashida M., Sezaki H. Transport of cephalexin to the CSF directly from the nasal cavity. J. Pharm. Pharmacol. 43:1991;449-451.
6. Sakane T., Akizuki M., Taki Y., Yamashita S., Sezaki H., Nadai T. Direct drug transport from rat nasal cavity to the cerebral fluid: The relation to the molecular weight of drugs. J. Pharm. Pharmacol. 47:1995;379-381.
7. K.S.E. Su, Nasal route of peptide and protein drug delivery, in: V.H.L. Lee (Ed.), Peptide and Protein Drug Delivery, Marcel Dekker, New York, 1991.
8. Su K.S.E., Campanale K.M., Mendelsohn L.G., Kerchmer G.A., Gries C.L. Nasal delivery of polypeptides. I: Nasal absorption of enkephalins in rats. J. Pharm. Sci. 74:1985;394-398.
9. Baldwin P.A., Klingbeil C.K., Grimm C.C., Longenecker J.P. The effect of sodium tauro-24,25-dihydrofusidate on the nasal absorption of human growth hormone in three animal models. Pharm. Res. 7:1990;547-552.
10. A.N. Fisher, Absorption across the nasal mucosa of animal species: Compounds applied and mechanisms involved, Prog. Drug. Metab. (1990) 87-145.
11. Fisher A.N., Ferraj N.F., O'Hagan D.T., Jabbal-Gill I., Johansen B.R., Davis S.S., Illum L. Effect of L-α-lysophosphatidylcholine on the nasal absorption of human growth hormone in three animal species. Int. J. Pharm. 74:1991;147-156.
12. Hirai S., Yashiki T., Matsuzawa T., Mima H. Absorption of drugs from the nasal mucosa of rats. Int. J. Pharm. 7:1981;317-325.
13. Reardon P.M., Gochoco C.H., Audus K.L., Wilson G., Smith P.L. In vitro nasal transport across ovine mucosa: Effects of ammonium glycyrrhinate on electrical properties and permeability of growth hormone releasing peptide, mannitol and lucifer yellow. Pharm. Res. 10:1993;553-561.
14. Bechgaard E., Gizurarson S., Joergensen L., Larsen R. The viability of isolated rabbit mucosa in the Ussing chamber, and the permeability of insulin across the membrane. Int. J. Pharm. 87:1992;125-132.
15. Cremaschi D., Rossetti C., Draghetti M.T., Manzoni C., Aliverti V. Active transport of polypeptides in rabbit respiratory nasal mucosa. J. Control. Release. 13:1990;319-320.
16. Audus K.L., Bartel R.L., Hidalgo I.J., Borchardt R.T. The use of cultured epithelial and endothelial cells for drug transport and metabolism studies. Pharm. Res. 7:1990;435-451.
17. Audus K.L., Tavakoli-Saberi M.R. Aminopeptidases of newborn bovine nasal epithelial cell cultures. Int. J. Pharm. 76:1991;247-255.
18. Illum L., Davis S.S. Intranasal insulin. Clin. Pharmacokinet. 23:1992;30-41.
19. Hilsted J., Madsbad S., Hvidberg A., Rasmussen M.H., Krarup T., Ipsen H., Hansen B., Pedersen M., Djurup R., Oxenboll B. Intranasal insulin therapy: The clinical realities. Diabetologica. 38:1995;680-684.
20. Merkus F.W.H.M., Schipper N.G.M., Verhoef J.C. The influence of absorption enhancers on intranasal insulin absorption in normal and diabetic subjects. J. Control. Release. 41:1996;69-75.
21. C.S. Barrow, Toxicology of the Nasal Passages, Hemisphere Publishing Corporation, 1986.
22. Petruson B., Hansson H.A., Karlsson G. Structural and functional aspects of cells in the nasal mucociliary system. Arch. Otolaryngol. 110:1984;576-581.
23. Mackay M., Williamson I., Hastewell J. Cell biology of epithelia. Adv. Drug Deliv. Rev. 7:1991;313-338.
24. Cornaz A.L., Burri P. Nasal mucosa as an absorption barrier. Eur. J. Pharm. Biopharm. 40:1994;261-270.
25. Sarkar M.A. Drug metabolism in the nasal mucosa. Pharm. Res. 9:1992;1-9.
26. C.G. Peters, Routes of administration for polar compounds of moderate molecular weight with particular reference to analogues of somatostatin, in: S.S. Davis, L. Illum, E. Tomlinson (Eds.), Delivery Systems for Peptide Drugs, Plenum Press, New York, 1986, pp. 255-263.
27. Schipper N.G.M., Verhoef J.C., Merkus F.W.H.M. The nasal mucociliary clearance: Relevance to nasal drug delivery. Pharm. Res. 8:1991;807-814.
28. Fisher A.N., Illum L., Davis S.S., Schacht E.H. Di-iodo-L-tyrosine-labelled dextrans as molecular size markers of nasal absorption in the rat. J. Pharm. Pharmacol. 44:1992;550-554.
29. Werner U., Kissel T. Development of a human nasal cell culture model and its suitability for transport and metabolism studies under in vitro conditions. Pharm. Res. 12:1995;565-571.
30. Werner U., Kissel T. In-vitro cell culture models of the nasal epithelium: A comparative histochemical investigation of their suitability for drug transport studies. Pharm. Res. 13:1996;978-988.
31. U. Werner, Models of the nasal and intestinal mucosa for investigations of drug transport and metabolism, Ph.D. Thesis, University of Marburg, Cuvillier Verlag, Göttingen, 1995.
32. Walter E., Kissel T. Metabolic differences in subclones of a human intestinal cell line (Caco-2): presystemic cleavage of leu- and met-enkephalin. Pharm. Pharmacol. Lett. 3:1994;221-224.
33. Jorgensen L., Beechgaard E. Intranasal permeation of thyrotropin-releasing hormone: in vitro study of permeation and enzymatic degradation. Int. J. Pharm. 107:1994;231-237.
34. Cremaschi D., Rossetti C., Draghetti M.T., Manzoni C., Aliverti V. Active transport of polypeptides in rabbit respiratory nasal mucosa. J. Control. Release. 13:1990;319-320.
35. Moss J., Bundgaard H. Kinetics and pattern of degradation of thyrotropin-releasing hormone in human plasma. Pharm. Res. 7:1990;751-755.
36. Moss J., Buur A., Bundgaard H. Prodrugs of peptides. 8. In vitro study of intestinal metabolism and penetration of thyrotropin-releasing hormone (TRH) and its prodrugs. Int. J. Pharm. 66:1990;183-191.
37. Hussain M.A., Aungst B.J. Nasal absorption of leucine enkephalin in rats and the effects of aminopeptidase inhibition, as determined from percentage of dose unabsorbed. Pharm. Res. 9:1992;1362-1364.
38. Stratford R.E., Lee V.H.L. Aminopeptidase activity in homogenates of various absorptive mucosae in the albino rabbit: implications in peptide delivery. Int. J. Pharm. 30:1986;73-82.
39. Bechgaard E., Gizurarson S., Jorgensen L., Larsen R. The viability of isolated rabbit mucosa in the Ussing chamber, and the permeability of insulin across the membrane. Int. J. Pharm. 87:1992;125-132.